ProductUpdated on 2 October 2024
Innovative Cancer screening product
About
XGenera have a diagnostic for 12 cancers that is highly sensitive and specific. It is currently undergoing development on 8000 patients. The company is looking for commercial opportunities.
Similar opportunities
Service
Kevin Moreton
Head of International Programmes at Health Innovation North West Coast
Liverpool, United Kingdom
Partnership
- Consulting
- Manufacturing
Ben Sequerra
CEO at Metapy
Sheffield, United Kingdom
Service
Immersive Medical Device Development & Funding
Alastair Buchanan
CEO at Nudge Reality
Chester, Cheshire, United Kingdom